Nontoxic diffuse goiter
ICD-10 E04.0 is a billable code used to indicate a diagnosis of nontoxic diffuse goiter.
Nontoxic diffuse goiter is characterized by an enlargement of the thyroid gland without the presence of hyperthyroidism or malignancy. This condition is often associated with iodine deficiency, which is a critical factor in thyroid hormone synthesis. The thyroid gland compensates for low hormone levels by enlarging, leading to a diffuse goiter. Patients may present with a visible swelling in the neck, but they typically do not exhibit symptoms of thyroid dysfunction. Diagnosis is confirmed through clinical examination, thyroid function tests, and imaging studies such as ultrasound. Thyroid function tests usually reveal normal levels of thyroid hormones (T3 and T4) and thyroid-stimulating hormone (TSH). Management may include iodine supplementation, especially in areas where iodine deficiency is prevalent. Regular monitoring is essential to ensure that the goiter does not progress to a toxic state or develop nodules that may require further evaluation.
Thorough documentation of thyroid function tests, imaging studies, and clinical findings.
Patients presenting with neck swelling, routine check-ups for thyroid health, and follow-ups after iodine supplementation.
Ensure that all thyroid function tests are documented and that the absence of hyperthyroidism is clearly stated.
Documentation of patient history, physical examination findings, and any referrals to specialists.
Initial evaluation of thyroid enlargement and management of iodine deficiency.
Document any patient education provided regarding iodine intake and thyroid health.
Used to evaluate thyroid function in patients with goiter.
Document the reason for the test and the results.
Endocrinologists may require additional tests based on patient history.
The primary cause is often iodine deficiency, which leads to insufficient thyroid hormone production and compensatory gland enlargement.
